XML 50 R41.htm IDEA: XBRL DOCUMENT v3.22.2.2
Fair Value Measurements - Narrative (Details)
3 Months Ended 6 Months Ended
May 19, 2021
USD ($)
milestone
Sep. 30, 2022
USD ($)
Dec. 31, 2021
USD ($)
Sep. 30, 2021
USD ($)
Sep. 30, 2022
USD ($)
Sep. 30, 2021
USD ($)
Mar. 31, 2022
USD ($)
Feb. 17, 2021
USD ($)
Jan. 04, 2021
USD ($)
milestone
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]                  
Fair value of contingent consideration upon acquisition         $ 1,142,000 $ 9,973,000      
Payment of contingent consideration for business acquisition         5,954,000 0      
Equity method investments   $ 22,900,000     22,900,000   $ 40,200,000    
Impairment of non-marketable investments   21,400,000   $ 0 21,400,000 0      
Equity investments included in other assets   10,900,000     10,900,000   2,900,000    
Unrealized gain, before tax         6,900,000        
Impairment of long-lived assets held-for-use   0   0 0 0      
Impairment of non-financial assets   0   $ 0 0 $ 0      
Fair Value, Measurements, Recurring | Level 1                  
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]                  
Investments for deferred compensation plan   27,969,000     $ 27,969,000   $ 28,431,000    
Small Technology Acquisition                  
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]                  
Future potential earn-out payments $ 10,000,000                
Number of technical development milestones | milestone 3                
Fair value of contingent consideration upon acquisition $ 10,000,000                
Small Technology Acquisition | Second Technical Development Milestone                  
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]                  
Payment of contingent consideration for business acquisition   4,000,000              
Small Technology Acquisition | First Technical Development Milestone                  
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]                  
Payment of contingent consideration for business acquisition     $ 900,000            
Mevo                  
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]                  
Future potential earn-out payments               $ 17,000,000  
Contingent consideration               $ 3,400,000  
Small Technology Acquisition Two                  
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]                  
Future potential earn-out payments                 $ 3,000,000
Number of technical development milestones | milestone                 2
Small Technology Acquisition Two | First Technical Development Milestone                  
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]                  
Payment of contingent consideration for business acquisition   $ 2,000,000